In the news.
ACGT-Netter Fund awards grant for neuroblastoma CAR T-cell therapy
ACGT has awarded a collaborative research grant to two scientists at Children’s Hospital of Philadelphia who are developing a cell and gene therapy for childhood cancers.
Read More
ACGT-Netter Fund awards grant for neuroblastoma CAR T-cell therapy
ACGT has awarded a collaborative research grant to two scientists at Children’s Hospital of Philadelphia who are developing a cell and gene therapy for childhood cancers.
Read More
ACGT-Netter Fund awards grant for pediatric brain tumor research
The ACGT-Barbara Netter Fund has awarded a collaboration grant to support the development of T-cell therapy for pediatric brain tumors.
Read More
ACGT-Netter Fund awards grant for pediatric brain tumor research
The ACGT-Barbara Netter Fund has awarded a collaboration grant to support the development of T-cell therapy for pediatric brain tumors.
Read More
FDA approves Aucatzyl CAR T-cell therapy for acute lymphoblastic leukemia (ALL)
The US Food and Drug Administration (FDA) has approved Autolus Therapeutics’ Aucatzyl (obecabtagene autoleucel) to treat acute lymphoblastic leukemia (ALL).
Read More
FDA approves Aucatzyl CAR T-cell therapy for acute lymphoblastic leukemia (ALL)
The US Food and Drug Administration (FDA) has approved Autolus Therapeutics’ Aucatzyl (obecabtagene autoleucel) to treat acute lymphoblastic leukemia (ALL).
Read More
